Freshpet reported third-quarter 2026 net sales of $317.8 million, up 10.0% from the prior year, and raised its full-year 2026 net sales growth guidance to 12% to 13%. Net income fell to $29.7 million from $101.7 million, a comparison that includes a $77.9 million prior-year tax benefit, and diluted earnings per share were $0.58 versus $1.86.
Q3 net sales of $317.8 million, up 10.0%; Adjusted EBITDA of $64.5 million, or 20.3% of net sales
Q3 net income of $29.7 million versus $101.7 million a year earlier, which included a $77.9 million tax benefit
2026 guidance: net sales growth of 12% to 13% (previously 10% to 12%); Adjusted EBITDA of $215 million to $220 million (previously $210 million to $220 million)
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Freshpet's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$1.10B
+13.0%
$2.64
+183.9%
12.6%
FY2024
$975.18M
+27.2%
$0.93
—
4.8%
FY2023
$766.89M
+28.8%
$-0.70
—
-4.4%
FY2022
$595.34M
+39.9%
$-1.29
—
-10.0%
FY2021
$425.49M
+33.5%
$-0.69
—
-7.0%
Frequently asked questions
When is Freshpet's next earnings date?
Freshpet has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Freshpet earn last quarter?
For the quarter ended Sep 2026, Freshpet reported diluted EPS of $0.58 (-68.8% year over year) on revenue of $317.84M (+10.0%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.